You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

~ Buy the CROSPOVIDONE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) CROSPOVIDONE

✉ Email this page to a colleague

« Back to Dashboard

Branded drugs containing CROSPOVIDONE excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	ZYPREXA	olanzapine	0002-4112	CROSPOVIDONE
Eli Lilly and Company	EVISTA	raloxifene hydrochloride	0002-4184	CROSPOVIDONE
ER Squibb & Sons LLC	BARACLUDE	entecavir	0003-1611	CROSPOVIDONE
ER Squibb & Sons LLC	REYATAZ	atazanavir	0003-3624	CROSPOVIDONE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing CROSPOVIDONE excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Eli Lilly and Company	olanzapine	0002-4112	CROSPOVIDONE
Eli Lilly and Company	raloxifene hydrochloride	0002-4184	CROSPOVIDONE
ER Squibb & Sons LLC	entecavir	0003-1611	CROSPOVIDONE
ER Squibb & Sons LLC	atazanavir	0003-3624	CROSPOVIDONE
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.